David Bellovin
Five Prime Therapeutics · Bristol-Myers Squibb · Glaxosmithkline Intellectual Property (No. 4) Limited
Total Patents:
12
Overall Rank:
#398,939
Years Active:
2017–2025
Five Prime Therapeutics Rank:
#4